QUE — Spinal Muscular Atrophy Newborn Screening Test System Class II

FDA Device Classification

FDA product code QUE covers "Spinal Muscular Atrophy Newborn Screening Test System", a Class II medical device regulated under 21 CFR 866.5980. Submissions are reviewed by the Immunology panel. At least 2 recent 510(k) clearances have been granted under this product code.

Classification details

Product Code
QUE
Device Class
Class II
Regulation Number
866.5980
Submission Type
510(k)
Review Panel
MG
Medical Specialty
Immunology
Implant
No

Definition

A Spinal Muscular Atrophy (SMA) newborn screening test system is a prescription device intended to detect homozygous deletion of exon 7 or other similar mutations in the SMN1 (Survival Motor Neuron 1) gene of DNA obtained from dried blood spot specimens on filter paper using a polymerase chain reaction-based test as an aid in screening newborns for SMA. Presumptive positive results are intended to be followed up by diagnostic confirmatory testing.

Recent 510(k) clearances

K-NumberApplicantDevice NameDate
K262893RevvityEonis™ SMA kitSep 30, 2026
DEN200044PerkinelmerEonis SCID-SMA KitNov 9, 2022

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.